BioSpace News Archive

Business

Altimmune Elects Mitchel Sayare, Ph.D. as Chairman of its Board of Directors

The Board’s current Chairman, David Drutz, M.D., will remain on as Chairman of the Compensation Committee and Member of the Board.

January 3, 2018
·
4 min read
Drug Development

Cantex Pharma Announces FDA Orphan Drug Designation Has Been Granted to CX-01 for Treatment of AML

Cantex is currently conducting a 75-patient randomized phase IIb study in more than 20 U.S. medical centers to determine whether CX-01 can improve the efficacy of front-line chemotherapy of AML.

January 3, 2018
·
2 min read
Progenitor Life Sciences to Unveil Proprietary Next Generation “Off-the-Shelf” CAR-T Cell Development Workflow at the Biotech Showcase Annual Conference

Progenitor Life Sciences today announced that it will present at Biotech Showcase 2018, January 8–10, during JPMorgan Healthcare Conference week.

January 3, 2018
·
2 min read
Deals

BIOCRATES Life Sciences AG Acquires Metanomics Health GmbH to Create a New Global Leader in Metabolomics and Early Disease Detection

BIOCRATES Life Sciences, a global leader in targeted metabolomics, announced today the acquisition of Metanomics Health GmbH.

January 3, 2018
·
4 min read
Biotech Beach

MRI Interventions ClearPoint Neuro Navigation System Utilized for the First Time in Minnesota

University of Minnesota Health offers real-time MRI guided minimally invasive brain surgery.

January 3, 2018
·
5 min read
Policy

Tetraphase Pharmaceuticals Announces Submission of NDA to FDA for Eravacycline for the Treatment of Complicated Intra-Abdominal Infections (cIAI)

The submission includes data from the IGNITE1 and IGNITE 4 phase 3 clinical trials, in which twice-daily IV eravacycline was well tolerated and achieved high clinical cure rates in patients with cIAI.

January 3, 2018
·
6 min read
Business

Foamix Names Mr. David Domzalski as a Member of the Board of Foamix Pharmaceuticals

Mr. Domzalski has 25 years of experience in the pharmaceutical industry.

January 3, 2018
·
3 min read
Zealand Pharma Major Shareholder Announcement: Wellington Management Group LLP, U.S.

Wellington Management Company have increased their investment in Zealand Pharma so they now hold 5.06% of Zealand Pharma’s outstanding shares.

January 3, 2018
·
1 min read
Drug Development

Galapagos NV: Update on Progress in Cystic Fibrosis Programs

The company provided an update on several aspects of its cystic fibrosis (CF) program.

January 3, 2018
·
9 min read
Biotech Beach

BioPhotas Launches the Newest Model of the Celluma Series

BioPhotas announces the commercial introduction of the Celluma HOME, a fourth model in the Celluma Series of light therapy devices.

January 3, 2018
·
2 min read